Search Results - Khadempar, Saedeh

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Cytotoxic T Lymphocyte Antigen-4 Gene Variants in Type 2 Diabetic Patients with or without Neuropathy

    Cytotoxic T Lymphocyte Antigen-4 Gene Variants in Type 2 Diabetic Patients with or without Neuropathy by Kiani, Javad, Khadempar, Saedeh, Hajilooi, Mehrdad, Rezaei, Hamzeh, Keshavarzi, Fatemeh, Solgi, Ghasem

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Lansoprazole as a potent HDAC2 inhibitor for treatment of colorectal cancer: An in-silico analysis and experimental validation

    Lansoprazole as a potent HDAC2 inhibitor for treatment of colorectal cancer: An in-silico analysis and experimental validation by Khadempar, Saedeh, Lotfi, Marzieh, Haghiralsadat, Fatemeh, Saidijam, Massoud, Ghasemi, Nasrin, Afshar, Saeid

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    CRISPR–Cas9 in genome editing: Its function and medical applications

    CRISPR–Cas9 in genome editing: Its function and medical applications by Khadempar, Saedeh, Familghadakchi, Shokoufeh, Motlagh, Roozbeh Akbari, Farahani, Najmeh, Dashtiahangar, Maryam, Rezaei, Hamzeh, Gheibi Hayat, Seyed Mohammad

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Lack of association between rs1800795 (-174 G/C) polymorphism in the promoter region of interleukin-6 gene and susceptibility to type 2 diabetes in Isfahan population

    Lack of association between rs1800795 (-174 G/C) polymorphism in the promoter region of interleukin-6 gene and susceptibility to type 2 diabetes in Isfahan population by Ghavimi, Reza, Sharifi, Mohammadreza, Mohaghegh, Mohammad, Mohammadian, Hossein, Khadempar, Saedeh, Rezaei, Hamzeh

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Harnessing CRISPR/Cas9 technology in cardiovascular disease

    Harnessing CRISPR/Cas9 technology in cardiovascular disease by Rezaei, Hamzeh, khadempar, Saedeh, Farahani, Najmeh, Hosseingholi, Elaheh Zadeh, hayat, Seyed Mohammad Gheibi, Sathyapalan, Thozhukat, Sahebkar, Amir hossein

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: